Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 19/20 | 0.45 |
| ▸ | CTSD | P07339 | 3/20 | 0.45 |
| ▸ | CTSB | P07858 | 15/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3356768 | 0.83 | BACE1 (0.51) | BACE1CTSDCTSB | |
| SCHEMBL6703381 | 0.82 | BACE1 (0.48) | BACE1CTSDCTSB | |
| SCHEMBL5368852 | 0.81 | BACE1 (0.44) | BACE1CTSDCTSB | |
| SCHEMBL6703413 | 0.80 | BACE1 (0.46) | BACE1CTSDCTSB | |
| SCHEMBL5389512 | 0.79 | BACE1 (0.54) | BACE1CTSDCTSB | |
| SCHEMBL6698514 | 0.79 | BACE1 (0.47) | BACE1CTSDCTSB | |
| SCHEMBL5579632 | 0.78 | BACE1 (0.39) | BACE1CTSDCTSBMEN1KMT2A | |
| SCHEMBL5579627 | 0.78 | BACE1 (0.39) | BACE1CTSDCTSBMEN1KMT2A | |
| SCHEMBL6695306 | 0.78 | BACE1 (0.49) | BACE1CTSDCTSB | |
| SCHEMBL5379633 | 0.77 | BACE1 (0.52) | BACE1CTSDCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040171881-A1 | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | PHARMACIA & UPJOHN COMPANY | 2004-09-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171881-A1 | N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives | BACE1, BACE2, PSEN1 | BACE1 1/4885CTSD 249/4885CTSB 317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.